MiMedx Group (MDXG) Reports In-Line Q1 EPS, Beats on Revenues; Offers FY Guidance

MiMedx Group (NASDAQ: MDXG) reported Q1 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $72.6 million versus the consensus estimate of $71.6 million.

GUIDANCE:

MiMedx Group sees FY2017 EPS of $0.31-$0.33, versus the consensus of $0.31. MiMedx Group sees FY2017 revenue of $303.5-307 million, versus the consensus of $303.4 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c